Biomarkers · Cardiometabolic
Apolipoprotein B to A1 Ratio (ApoB/ApoA1)
Lower values carry lower risk. Not measured in our NHANES panel; the curve is synthesised from the published association.
Hazard ratio relative to the curve's reference value, as synthesised from the published association.
Published hazard ratio1.08per SD (95% CI 1.17–1.98) · NHANES III (1988-1994), n=6,181 total participants (2,046 with MAFLD), followed through Dec 31, 2019, linked to National Death Index
Where people sit
Population percentiles (ratio) by sex and age band. Cycle or source as recorded in the catalogue.
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 0.46 | 0.64 | 0.81 | 1.02 | 1.43 | 175,553 | Walldius G, Jungner I,… |
| All | 40-59 | 0.52 | 0.71 | 0.88 | 1.09 | 1.48 | 175,553 | Walldius G, Jungner I,… |
| All | 60+ | 0.59 | 0.79 | 0.96 | 1.17 | 1.55 | 175,553 | Walldius G, Jungner I,… |
| All | all | 0.52 | 0.71 | 0.88 | 1.09 | 1.48 | 175,553 | Walldius G, Jungner I,… |
| Men | all | 0.57 | 0.78 | 0.96 | 1.18 | 1.60 | 175,553 | Walldius G, Jungner I,… |
| Women | all | 0.48 | 0.65 | 0.81 | 1.01 | 1.37 | 175,553 | Walldius G, Jungner I,… |
Sources
- Hazard curve: Synthesized from mortality_association (HR=1.0782807345834484 per_sd); per-SD log(HR)=0.075. Reported as per_unit HR=1.52 for all-cause mortality. Per 1-unit increase in continuous ApoB/ApoA1 ratio, multivariate Cox model adjusted for age, sex
- Fu C, Gong Y, Gao X, et al. Association between the ApoB/ApoA1 ratio and both the severity and mortality of metabolic dysfunction-associated fatty liver disease. BMC Gastroenterology. 2025;25:650.
Map Apolipoprotein B to A1 Ratio (ApoB/ApoA1) against another biomarker.